| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director
2 companies
Dambkowski Carl serves as a Chief Medical Officer at APGE and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 48 sells. Those positions are worth an estimated $6.7M at current prices.
Historically, Dambkowski Carl's trades have earned a below-average insider score of 47/100 across 20 rated trades. Over a 12-month horizon, 28.6% of those trades were profitable, with an average 12-month return of -47.9%.
The biggest single holding is APGE (~$4.0M) as Chief Medical Officer. The recent filings there lean toward selling, a net 161,470 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 5,500 | $134.17 | $737,935.00 | -3.2% | - | - | |
| Jun 22, 2026 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 26,400 | $132.60 | $3,500,640.00 | -12.8% | - | - | |
| Jun 12, 2026 | ORKA Oruka Therapeutics, Inc. | Director | Sell | 35,000 | $70.13 | $2,454,382.15 | -47.5% | +31.1% | - | |
| Jun 3, 2026 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 5,500 | $78.71 | $432,905.00 | -2.6% | +60.4% | - | |
| May 21, 2026 | ORKA Oruka Therapeutics, Inc. | Director | Sale+OE | 105,000 | $58.97 | $6,191,366.32 | -58.7% | +86.9% | - | |
| Jan 7, 2026 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 18,700 | $77.84 | $1,455,613.06 | -8.1% | +5.5% | - | |
| Dec 4, 2025 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 10,900 | $75.00 | $817,500.00 | -3.9% | -4.3% | - | |
| Nov 5, 2025 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,785 | $55.07 | $593,902.84 | -3.7% | +24.2% | - | |
| Oct 1, 2025 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 5,110 | $39.80 | $203,378.00 | -1.8% | +92.4% | - | |
| Sep 3, 2025 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 2,725 | $37.87 | $103,198.20 | -1.2% | +81.2% | +254.0% |